Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0E9JR
|
||||
Former ID |
DNC009409
|
||||
Drug Name |
Ethyl 2-cyano-2-(quinoxalin-2(1H)-ylidene)acetate
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529388] | ||
Structure |
Download2D MOL |
||||
Formula |
C13H11N3O2
|
||||
Canonical SMILES |
CCOC(=O)C(=C1C=NC2=CC=CC=C2N1)C#N
|
||||
InChI |
1S/C13H11N3O2/c1-2-18-13(17)9(7-14)12-8-15-10-5-3-4-6-11(10)16-12/h3-6,8,16H,2H2,1H3/b12-9-
|
||||
InChIKey |
XEXZOINHSIFHFY-XFXZXTDPSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Collagenase 3 | Target Info | Inhibitor | [529388] | |
NetPath Pathway | IL1 Signaling Pathway | ||||
PANTHER Pathway | Alzheimer disease-presenilin pathway | ||||
Plasminogen activating cascade | |||||
Pathway Interaction Database | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.